Current Patient Management for Bacterial Meningitis Simultaneously Affected by Stroke.

Area of Science:

• Neurology
• Infectious Diseases
• Critical Care Medicine

Background:

• Bacterial meningitis (BM) is a severe central nervous system infection with significant risks of mortality and long-term disability.
• Neurovascular complications, including stroke and cerebral sinus thrombosis, markedly worsen patient prognosis in BM.
• Current treatment challenges include optimizing pharmacotherapy to address both infection and neurological sequelae.

Purpose of the Study:

• To review the strategic management of bacterial meningitis complicated by neurovascular events.
• To highlight the importance of early diagnosis, empirical and targeted antimicrobial therapy, and adjunct treatments.
• To underscore the need for further research into optimal treatment algorithms for these complex cases.

Main Methods:

• Review of current clinical practices and literature regarding the management of bacterial meningitis with neurological complications.
• Analysis of standard-of-care treatments including antimicrobial therapy, dexamethasone, and potential roles for anticoagulants and neurosurgery.
• Identification of knowledge gaps and areas for future research, including clinical trials and retrospective studies.

Main Results:

• Early stabilization, rapid diagnostics, and prompt broad-spectrum antimicrobial therapy are essential.
• Targeted antibiotics, intravenous dexamethasone, anticoagulants, and neurosurgery are key components of management for complicated BM.
• Despite current strategies, treatment response varies, and adverse outcomes remain high, indicating a need for improved therapeutic approaches.

Conclusions:

• Effective management of bacterial meningitis with neurovascular complications requires a dual approach targeting the infection and its neurological sequelae.
• The current standard of care involves antimicrobial therapy and intravenous dexamethasone, with other interventions considered on a case-by-case basis.
• Further research is essential to refine treatment protocols and improve outcomes for patients with this life-threatening condition.